Table 6.
Number of subjects with a CSD in ambulatory BP | ||||
---|---|---|---|---|
Group | A | B | C | |
SBP | Screening | 1 (9) | 1 (2) | 3 (6) |
Tadalafil | 29 (170) | 33 (310) | 28 (130) | |
Placebo | 27 (96) | 28 (153) | 25 (90) | |
DBP | Screening | 2 (4) | 1 (3) | 7 (17) |
Tadalafil | 35 (195) | 35 (273) | 37 (162) | |
Placebo | 31 (175) | 29 (152) | 32 (120) |
CSD, Clinically significant decrease; (number of clinically significant decreases); SBP, systolic blood pressure; DBP diastolic blood pressure.